222 related articles for article (PubMed ID: 10217324)
1. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
2. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
[TBL] [Abstract][Full Text] [Related]
3. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.
Humanes B; Camaño S; Lara JM; Sabbisetti V; González-Nicolás MÁ; Bonventre JV; Tejedor A; Lázaro A
Nephrol Dial Transplant; 2017 Oct; 32(10):1645-1655. PubMed ID: 28340076
[TBL] [Abstract][Full Text] [Related]
5. [Nephrotoxicity and drug interaction of vancomycin (2)].
Toyoguchi T; Nakagawa Y
Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
[TBL] [Abstract][Full Text] [Related]
6. Effect of cilastatin on renal handling of vancomycin in rats.
Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
[TBL] [Abstract][Full Text] [Related]
7. Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy.
Zaballos M; Power M; Canal-Alonso MI; González-Nicolás MÁ; Vasquez-Jimenez W; Lozano-Lominchar P; Cabrerizo-Torrente P; Palencia-García N; Gago-Quiroga S; Ginel-Feito MD; Jiménez C; Lázaro A; González-Bayón L
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513824
[TBL] [Abstract][Full Text] [Related]
8. Renal excretion of vancomycin in rats with acute renal failure.
Nakamura T; Kokuryo T; Takano M; Inui K
J Pharm Pharmacol; 1997 Feb; 49(2):154-7. PubMed ID: 9055187
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation.
Markewitz A; Hammer C; Pfeiffer M; Zahn S; Drechsel J; Reichenspurner H; Reichart B
Transplantation; 1994 Mar; 57(6):865-70. PubMed ID: 8154033
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
[TBL] [Abstract][Full Text] [Related]
11. Exposure to imipenem/cilastatin causes nephrotoxicity and even urolithiasis in Wistar rats.
Tahri A; Lahyani A; Kallel R; Ayadi F; Boudawara T; Sahnoun Z
Toxicology; 2018 Jul; 404-405():59-67. PubMed ID: 29775647
[TBL] [Abstract][Full Text] [Related]
12. Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.
Hori Y; Aoki N; Kuwahara S; Hosojima M; Kaseda R; Goto S; Iida T; De S; Kabasawa H; Kaneko R; Aoki H; Tanabe Y; Kagamu H; Narita I; Kikuchi T; Saito A
J Am Soc Nephrol; 2017 Jun; 28(6):1783-1791. PubMed ID: 28052987
[TBL] [Abstract][Full Text] [Related]
13. Flucloxacillin worsens while imipenem-cilastatin protects against vancomycin-induced kidney injury in a translational rat model.
Pais GM; Marianski S; Valdez K; Melicor RP; Liu J; Rohani R; Chang J; Tong SYC; Davis JS; Scheetz MH
Br J Pharmacol; 2024 Mar; 181(5):670-680. PubMed ID: 37696768
[TBL] [Abstract][Full Text] [Related]
14. [Reduction of cisplatin toxicity by fosfomycin in animal models].
Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
[TBL] [Abstract][Full Text] [Related]
15. The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats.
Yoshiyama Y; Yazaki T; Wong PC; Beauchamp D; Kanke M
J Infect Chemother; 2001 Dec; 7(4):243-6. PubMed ID: 11810591
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of fosfomycin on cisplatin-induced nephrotoxicity in patients with lung cancer.
Rojanasthien N; Kumsorn B; Atikachai B; Leotrakul S; Thongprasert S
Int J Clin Pharmacol Ther; 2001 Mar; 39(3):121-5. PubMed ID: 11396752
[TBL] [Abstract][Full Text] [Related]
17. Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study.
Hakeam HA; AlAnazi L; Mansour R; AlFudail S; AlMarzouq F
Infect Dis (Lond); 2019 Aug; 51(8):578-584. PubMed ID: 31122098
[No Abstract] [Full Text] [Related]
18. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
19. Supplemental fosfomycin and/or steroids that reduce cisplatin-induced nephrotoxicity.
Umeki S; Watanabe M; Yagi S; Soejima R
Am J Med Sci; 1988 Jan; 295(1):6-10. PubMed ID: 2827472
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
